A PHASE II TRIAL OF BRENTUXIMAB VEDOTIN (BV) AND LENALIDOMIDE (LEN) IN RELAPSED AND REFRACTORY (R/R) CUTANEOUS (CTCL) AND PERIPHERAL (PTCL) T‐CELL LYMPHOMAS: PRELIMINARY RESULTS OF A PHASE II TRIAL. (12th June 2019)

Record Type:
Journal Article
Title:
A PHASE II TRIAL OF BRENTUXIMAB VEDOTIN (BV) AND LENALIDOMIDE (LEN) IN RELAPSED AND REFRACTORY (R/R) CUTANEOUS (CTCL) AND PERIPHERAL (PTCL) T‐CELL LYMPHOMAS: PRELIMINARY RESULTS OF A PHASE II TRIAL. (12th June 2019)
Main Title:
A PHASE II TRIAL OF BRENTUXIMAB VEDOTIN (BV) AND LENALIDOMIDE (LEN) IN RELAPSED AND REFRACTORY (R/R) CUTANEOUS (CTCL) AND PERIPHERAL (PTCL) T‐CELL LYMPHOMAS: PRELIMINARY RESULTS OF A PHASE II TRIAL
Authors:
William, B.M.
Abbasi, A.
Huang, Y.
Larbi, R.
Giali, R.
Yang, L.
Brammer, J.
Grantier, C.
Hoffman, C.
Ayyappan, S.
Baiocchi, R.
Epperla, N.
Christian, B.
Alinari, L.
Maddocks, K.
Chung, C.
Abstract:
Is Part Of:
Hematological oncology. Volume 37(2019)Supplement 2
Journal:
Hematological oncology
Issue:
Volume 37(2019)Supplement 2
Issue Display:
Volume 37, Issue 2 (2019)
Year:
2019
Volume:
37
Issue:
2
Issue Sort Value:
2019-0037-0002-0000
Page Start:
471
Page End:
472
Publication Date:
2019-06-12
Subjects:
Hematological oncology -- Periodicals
Hematology
Medical Oncology
616.99418005
Journal URLs:
http://onlinelibrary.wiley.com/ ↗
DOI:
10.1002/hon.150_2631 ↗
Languages:
English
ISSNs:
0278-0232
Deposit Type:
Legaldeposit
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:
British Library DSC - 4291.550000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store
Ingest File:
12427.xml